rs142822527

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001008537.3(NEXMIF):​c.2315G>A​(p.Arg772His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0001 in 1,209,534 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 47 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R772C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., 3 hem., cov: 23)
Exomes 𝑓: 0.000096 ( 0 hom. 44 hem. )

Consequence

NEXMIF
NM_001008537.3 missense

Scores

16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.65

Publications

1 publications found
Variant links:
Genes affected
NEXMIF (HGNC:29433): (neurite extension and migration factor) An inversion on the X chromosome which disrupts this gene and a G-protein coupled purinergic receptor gene located in the pseudoautosomal region of the X chromosome has been linked to X linked cognitive disability.[provided by RefSeq, Mar 2009]
NEXMIF Gene-Disease associations (from GenCC):
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability, Cantagrel type
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • myoclonic-astatic epilepsy
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.053863734).
BP6
Variant X-74742242-C-T is Benign according to our data. Variant chrX-74742242-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 474063.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 3 Unknown,XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEXMIFNM_001008537.3 linkc.2315G>A p.Arg772His missense_variant Exon 3 of 4 ENST00000055682.12 NP_001008537.1 Q5QGS0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEXMIFENST00000055682.12 linkc.2315G>A p.Arg772His missense_variant Exon 3 of 4 1 NM_001008537.3 ENSP00000055682.5 Q5QGS0
NEXMIFENST00000616200.2 linkc.2315G>A p.Arg772His missense_variant Exon 3 of 5 1 ENSP00000480284.1 Q5QGS0
NEXMIFENST00000642681.2 linkc.2315G>A p.Arg772His missense_variant Exon 3 of 3 ENSP00000495800.1 A0A2R8YEQ5

Frequencies

GnomAD3 genomes
AF:
0.000143
AC:
16
AN:
111911
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000162
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000950
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000169
Gnomad OTH
AF:
0.000668
GnomAD2 exomes
AF:
0.0000873
AC:
16
AN:
183180
AF XY:
0.0000886
show subpopulations
Gnomad AFR exome
AF:
0.0000764
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000171
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000957
AC:
105
AN:
1097623
Hom.:
0
Cov.:
31
AF XY:
0.000121
AC XY:
44
AN XY:
362991
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26389
American (AMR)
AF:
0.000114
AC:
4
AN:
35202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19377
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30199
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54135
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40521
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.000113
AC:
95
AN:
841592
Other (OTH)
AF:
0.000109
AC:
5
AN:
46071
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000143
AC:
16
AN:
111911
Hom.:
0
Cov.:
23
AF XY:
0.0000880
AC XY:
3
AN XY:
34103
show subpopulations
African (AFR)
AF:
0.000162
AC:
5
AN:
30817
American (AMR)
AF:
0.0000950
AC:
1
AN:
10527
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2651
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3553
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2676
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6071
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.000169
AC:
9
AN:
53192
Other (OTH)
AF:
0.000668
AC:
1
AN:
1498
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000198
Hom.:
9
Bravo
AF:
0.0000945
ESP6500AA
AF:
0.000261
AC:
1
ESP6500EA
AF:
0.000297
AC:
2
ExAC
AF:
0.0000741
AC:
9
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 15, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:2
Oct 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NEXMIF: BP4, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.90
CADD
Benign
9.0
DANN
Benign
0.13
DEOGEN2
Benign
0.020
T;T;.
FATHMM_MKL
Benign
0.058
N
LIST_S2
Benign
0.51
.;T;T
M_CAP
Benign
0.0048
T
MetaRNN
Benign
0.054
T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
2.7
PrimateAI
Benign
0.27
T
PROVEAN
Benign
1.9
N;.;.
REVEL
Benign
0.080
Sift
Benign
1.0
T;.;.
Sift4G
Benign
0.91
T;T;.
Polyphen
0.0
B;B;.
Vest4
0.038
MVP
0.068
MPC
0.28
ClinPred
0.0078
T
GERP RS
4.6
Varity_R
0.040
gMVP
0.14
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142822527; hg19: chrX-73962077; API